155 related articles for article (PubMed ID: 37814876)
1. [Quercetin improves pulmonary arterial hypertension in rats by regulating the HMGB1/RAGE/NF-κB pathway].
Zhang N; Qiu Q; Chen Y; Sun Z; Lu G; Wang L; Kang P; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1606-1612. PubMed ID: 37814876
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane improves circulatory function and pulmonary fibrosis in rats with pulmonary arterial hypertension through inhibiting NF-κB signaling pathway.
Zhao X; Bai X; Li JL; Li SM; Xi J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10532-10540. PubMed ID: 31841209
[TBL] [Abstract][Full Text] [Related]
3. Chronic Normobaric Hypoxia Induces Pulmonary Hypertension in Rats: Role of NF-κB.
Fan J; Fan X; Li Y; Ding L; Zheng Q; Guo J; Xia D; Xue F; Wang Y; Liu S; Gong Y
High Alt Med Biol; 2016 Mar; 17(1):43-9. PubMed ID: 26788753
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
[TBL] [Abstract][Full Text] [Related]
6. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
7. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
8. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
9. [Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].
Wu XC; Liu Y; Bai ZP
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3055-3065. PubMed ID: 37381964
[TBL] [Abstract][Full Text] [Related]
10. [Effects of panax notoginseng saponins on pulmonary vascular remodeling in rats with pulmonary hypertension and its mechanisms].
Song ZY; Wang XY; Tian YN; Li ZL; Wang XT; Yuan LB; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):650-654. PubMed ID: 37308411
[No Abstract] [Full Text] [Related]
11. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
[TBL] [Abstract][Full Text] [Related]
12. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
[TBL] [Abstract][Full Text] [Related]
13. [Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway].
Zhang S; Tian YN; Song ZY; Wang XT; Wang XY; Xu JP; Yuan LB; Wang WT
Sheng Li Xue Bao; 2023 Aug; 75(4):503-511. PubMed ID: 37583037
[TBL] [Abstract][Full Text] [Related]
14. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
15. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin protects pulmonary artery hypertension in rats by activating NF-κB/TNF-α pathway.
Liu WY; Wang L; Lai YF
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7573-7581. PubMed ID: 31539149
[TBL] [Abstract][Full Text] [Related]
18. Research on rat models of hypobaric hypoxia-induced pulmonary hypertension.
Ma TT; Wang Y; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Yao XY; Gao ZM; Pan L
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3723-30. PubMed ID: 26502863
[TBL] [Abstract][Full Text] [Related]
19. [NF-κB inhibitor improves pulmonary vascular remodeling by reversing LPS-induced down-regulation of BMPRII].
Zhou MJ; Xing YJ; Yang J
Sheng Li Xue Bao; 2020 Oct; 72(5):541-550. PubMed ID: 33106824
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
